Cargando…
Therapeutic Targeting of DNA Damage Response in Cancer
DNA damage response (DDR) is critical to ensure genome stability, and defects in this signaling pathway are highly associated with carcinogenesis and tumor progression. Nevertheless, this also provides therapeutic opportunities, as cells with defective DDR signaling are directed to rely on compensat...
Autores principales: | Choi, Wonyoung, Lee, Eun Sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836062/ https://www.ncbi.nlm.nih.gov/pubmed/35163621 http://dx.doi.org/10.3390/ijms23031701 |
Ejemplares similares
-
Strategies for targeting the DNA damage response for cancer therapeutics
por: Zhang, Dan, et al.
Publicado: (2012) -
Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer
por: Catalano, Fabio, et al.
Publicado: (2022) -
Interplay between the DNA Damage Response and Immunotherapy Response in Cancer
por: Lee, Elizabeth Chun Yong, et al.
Publicado: (2022) -
Targeting the DNA Damage Response for Cancer Therapy
por: Wang, Ruoxi, et al.
Publicado: (2023) -
Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
por: Kiss, Robert Csaba, et al.
Publicado: (2021)